Cargando…
Reduced risk of post ERCP pancreatitis in statin users
BACKGROUND: One of the most feared complications of endoscopic retrograde cholangiopancreatography (ERCP), with an incidence of 3.5 to 15%, is post ERCP pancreatitis (PEP). Given the role of statins in the reduction of systemic and pancreatic intraluminal inflammation, we hypothesized that the use o...
Autores principales: | Hadi, Yousaf Bashir, Naqvi, Syeda Fatima, Abdelqader, Abdelhai, Kupec, Justin, Nasr, John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7181588/ https://www.ncbi.nlm.nih.gov/pubmed/32326889 http://dx.doi.org/10.1186/s12876-020-01264-5 |
Ejemplares similares
-
Outcomes of SARS-CoV-2 infection in patients with celiac disease: a multicenter research network study
por: Hadi, Yousaf Bashir, et al.
Publicado: (2022) -
Detection of hiatal hernias: comparison of high-resolution manometry and physician reported in an obese-predominant population
por: Shah-Khan, Sardar Momin, et al.
Publicado: (2019) -
Somatostatin administration prior to ERCP is effective in reducing the risk of post-ERCP pancreatitis in high-risk patients
por: ZHAO, LI-NA, et al.
Publicado: (2014) -
Outcomes of SARS-CoV-2 infection in patients with pulmonary sarcoidosis: A multicenter retrospective research network study
por: Hadi, Yousaf B., et al.
Publicado: (2021) -
Prevention of Post-ERCP Pancreatitis
por: Donnellan, F., et al.
Publicado: (2012)